FDA Inspection 1100650 — Northern Illinois Blood Bank
The FDA completed an inspection of Northern Illinois Blood Bank on Aug 6, 2019 in Freeport, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 6, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Freeport, IL (United States)